Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains

被引：5

作者：

Kuwahara, R ^{[1
]}

Kumashiro, R ^{[1
]}

Inoue, H ^{[1
]}

Tanabe, R ^{[1
]}

Tanaka, E ^{[1
]}

Hino, T ^{[1
]}

Ide, T ^{[1
]}

Koga, Y ^{[1
]}

Sata, M ^{[1
]}

机构：

[1] Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan

来源：

DIGESTIVE DISEASES AND SCIENCES | 2004年 / 49卷 / 02期

关键词：

hepatitis B virus; hepatic failure; lamivudine; YMDD motif; adefovir dipivoxil; drug resistance;

D O I：

10.1023/B:DDAS.0000017455.39171.56

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：300 / 303

页数：4

共 30 条

[1] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[2]

Bruno R, 2001, AM J GASTROENTEROL, V96, P265, DOI 10.1111/j.1572-0241.2001.03501.x

[3] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[4] Lamivudine as initial treatment for chronic hepatitis B in the United States [J].

Dienstag, JL ;

Schiff, ER ;

Wright, TL ;

Perrillo, RP ;

Hann, HWL ;

Goodman, Z ;

Crowther, L ;

Condreay, LD ;

Woessner, M ;

Rubin, M ;

Brown, NA .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263

[5] A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection [J].

Gilson, RJC ;

Chopra, KB ;

Newell, AM ;

Murray-Lyon, IM ;

Nelson, MR ;

Rice, SJ ;

Tedder, RS ;

Toole, J ;

Jaffe, HS ;

Weller, IVD .

JOURNAL OF VIRAL HEPATITIS, 1999, 6 (05) :387-395

[6] Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].

Hadziyannis, SJ ;

Tassopoulos, NC ;

Heathcote, EJ ;

Chang, TT ;

Kitis, G ;

Rizzetto, M ;

Marcellin, P ;

Lim, SG ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807

[7] Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay [J].

Kamisango, K ;

Kamogawa, C ;

Sumi, M ;

Goto, S ;

Hirao, A ;

Gonzales, F ;

Yasuda, K ;

Iino, S .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (02) :310-314

[8] Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B [J].

Kweon, YO ;

Goodman, ZD ;

Dienstag, JL ;

Schiff, ER ;

Brown, NA ;

Burkhardt, E ;

Schoonhoven, R ;

Brenner, DA ;

Fried, MW .

JOURNAL OF HEPATOLOGY, 2001, 35 (06) :749-755

[9] A one-year trial of lamivudine for chronic hepatitis B [J].

Lai, CL ;

Chien, RN ;

Leung, NWY ;

Chang, TT ;

Guan, R ;

Tai, DI ;

Ng, KY ;

Wu, PC ;

Dent, JC ;

Barber, J ;

Stephenson, SL ;

Gray, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :61-68

[10] Medical progress - Hepatitis B virus infection [J].

Lee, WM .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1733-1745

← 1 2 3 →